According to Verrica Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$0.72. In 2022 the company made an earnings per share (EPS) of -$1.11 an increase over its 2021 EPS that were of -$1.75.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$0.71 | -36% |
2022 | -$1.11 | -36.59% |
2021 | -$1.75 | -24.56% |
2020 | -$2.32 | 51.33% |
2019 | -$1.53 | -26.34% |
2018 | -$2.08 | 213.54% |
2017 | -$0.66 |